Use your antibodies-online credentials, if available.
No Products on your Comparison List.
Your basket is empty.
Find out more
TEAD4 product is a member of the transcriptional enhancer factor (TEF) family of transcription factors, which contain the TEA/ATTS DNA-binding domain. Additionally we are shipping TEAD4 Proteins (6) and many more products for this protein.
Showing 10 out of 75 products:
Human Monoclonal TEAD4 Primary Antibody for IP, RNAi - ABIN563135
Benhaddou, Keime, Ye, Morlon, Michel, Jost, Mengus, Davidson: Transcription factor TEAD4 regulates expression of myogenin and the unfolded protein response genes during C2C12 cell differentiation. in Cell death and differentiation 2012
Show all 3 references for ABIN563135
Chicken Polyclonal TEAD4 Primary Antibody for IF, WB - ABIN2777935
Appukuttan, McFarland, Davies, Atchaneeyasakul, Zhang, Babra, Pan, Rosenbaum, Acott, Powers, Stout: Identification of novel alternatively spliced isoforms of RTEF-1 within human ocular vascular endothelial cells and murine retina. in Investigative ophthalmology & visual science 2007
Show all 2 references for ABIN2777935
Chicken Polyclonal TEAD4 Primary Antibody for IHC, WB - ABIN2780491
Chen, Baty, Maeda, Brooks, Baker, Ueyama, Gursoy, Saba, Salama, London, Stewart: Transcription enhancer factor-1-related factor-transgenic mice develop cardiac conduction defects associated with altered connexin phosphorylation. in Circulation 2004
the transcriptional regulators in the Hippo pathway, Tead4 and Yap1 (show YAP1 Antibodies), are required for general vertebrate epimorphic regeneration as well as for organ size control in appendage regeneration
Tead4 cooperates with AP1 (show FOSB Antibodies) transcription factors to coordinate target gene transcription.
TEAD4 and KLF5 (show KLF5 Antibodies), in collaboration, promoted triple negative breast cancer cell proliferation and tumor growth in part by inhibiting p27 (show PAK2 Antibodies) gene transcription
potential anti-oxidation gene and can prevent H2O2-induced endothelial cell oxidative damage by activating Klotho (show KL Antibodies)
TEAD4 overexpression induced p16 (show CDKN2A Antibodies) in HAoSMCs homozygous for the nonrisk coronary disease allele, but not for the risk allele.
TAZ (show TAZ Antibodies) negatively regulate transcription of DeltaNp63 through TEAD1,2,3 and 4 transcription factors.
Our findings suggest that genetic variants of Hippo pathway genes, particularly YAP1 (show YAP1 Antibodies) rs11225163, TEAD1 (show TEAD1 Antibodies) rs7944031 and TEAD4 rs1990330, may independently or jointly modulate survival of CM patients.
the peptides TEF3 (show TRIM37 Antibodies)-11-66 and TEF3 (show TRIM37 Antibodies)-1197-434 functioned as two independent activation domains, suggesting that N-terminal domain of TEF3 (show TRIM37 Antibodies)-1 also has transcriptional activation capacity
Edg-1 (show HEXIM1 Antibodies) is a potential target gene of RTEF-1 and is involved in RTEF-1-induced angiogenesis in endothelial cells.
the multilevel perturbations of TEAD4 at epigenetic, transcriptional and posttranslational levels may contribute to GC development.
These data suggest that TFF3 (show TFF3 Antibodies) and survivin (show BIRC5 Antibodies) expressions play a vital role in gastric cancer development, and these two proteins are important markers for prognosis in gastric cancer.
Dual-luciferase reporter gene analysis showed that RTEF-1 is a direct target of mir-125a-5p, which regulates angiogenesis by repressing RTEF-1 expression and modulating eNOS and VEGF expression.
TEAD4 establishes the energy homeostasis essential for blastocoel formation.
These results show that RTEF-1-stimulated IGFBP-1 (show IGFBPI Antibodies) expression may be central to the mechanism by which RTEF-1 attenuates blood glucose levels.
Vgll1 (show VGLL1 Antibodies) interacts with TEAD4 in a manner similar to the transcription coactivators, as well as oncogenes YAP (show YAP1 Antibodies) and TAZ (show TAZ Antibodies), despite having a varied primary sequence. Vgll1 (show VGLL1 Antibodies) has the potential to promote cancer progression.
endothelial-specific RTEF-1 overexpressing mice had enhanced angiogenic sprouting and vascular structure remodeling, resulting in the formation of a denser and more highly interconnected superficial capillary plexus
Data suggest that altered subcellular localization of TEAD4 in blastomeres dictates first mammalian cell fate specification.
TEAD factors directly induce Myogenin (show MYOG Antibodies), CDKN1A (show CDKN1A Antibodies) and Caveolin 3 (show CAV3 Antibodies) expression to promote myoblast differentiation.
Gata3 (show GATA3 Antibodies) and Cdx2 (show CDX2 Antibodies) can act in parallel pathways downstream of Tead4 to induce the expression of common and independent targets in the trophoblast lineage, whereas Oct4 (show POU5F1 Antibodies) is required for continued repression of trophoblast fate in the embryonic lineage
Novel RTEF-1 transcripts are present within human ocular vascular endothelial cells and mouse neural retina during normal and retinopathy of prematurity development, and alternatively spliced products are produced under hyperoxic and hypoxic conditions
RTEF-1 regulated smooth muscle alpha-actin (show ACTA2 Antibodies) transcription in myofibroblasts, but not in differentiated smooth muscle
This gene product is a member of the transcriptional enhancer factor (TEF) family of transcription factors, which contain the TEA/ATTS DNA-binding domain. It is preferentially expressed in the skeletal muscle, and binds to the M-CAT regulatory element found in promoters of muscle-specific genes to direct their gene expression. Alternatively spliced transcripts encoding distinct isoforms, some of which are translated through the use of a non-AUG (UUG) initiation codon, have been described for this gene.
TEA domain family member 4
, M-CAT binding factor
, M-CAT-binding factor
, transcriptional enhancer factor TEF-3
, related transcription enhancer factor 1B
, transcription factor 13-like 1
, transcription factor RTEF-1
, transcriptional enhancer factor 1-related
, transcriptional enhancer factor 3
, transcriptional enhancer factor 1-related protein
, ETF-related factor 2
, ETF-related factor-2
, FGF-regulated 19
, TEF-1-related factor 1
, TEF-1-related factor FR-19